Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome

Br J Haematol. 2024 Sep;205(3):1220-1224. doi: 10.1111/bjh.19609. Epub 2024 Jun 21.

Sofia Bentivegna^{1

2}, Christophe Côme^{1

2}, Bo Porse^{2

3

4}, Mads Hald Andersen^{5

6}, Kirsten Grønbæk^{1

2

4}

¹ Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
² Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
³ The Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.
⁶ Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

No abstract available

Publication types